Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 2, 2024Open Access

Dihydromyricetin promotes GLP-1 secretion to improve insulin resistance via “gut microbiota-CDCA”

View Full Paper
Ask AI
Bookmark
Share

Authors

PLPengfei LiYZYong ZhangHLHedong Lang

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Li et al. (2024) studied this question.

synapsesocial.com/papers/68e669a3b6db6435875f529ehttps://doi.org/10.1101/2024.05.28.596357
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Obesity Phenotypes, Diabetes, and Cardiovascular Diseases2020 · 2,022 citations
  2. 2Therapeutic Perspectives of CD26 Inhibitors in Imune-Mediated Diseases2022 · 27 citations
  3. 3GLP-1 physiology informs the pharmacotherapy of obesity2021 · 502 citations
  4. 4Dihydromyricetin Enhances Exercise-Induced GLP-1 Elevation through Stimulating cAMP and Inhibiting DPP-42022 · 14 citations
  5. 5CD4CD8αα IELs: They Have Something to Say2019 · 37 citations